Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves' disease

Journal of Endocrinological Investigation

Volumn 32, Issue 1, 2009, Pages 52-56

  De Groot, L J ^a,b   Ha Shin, Y ^a   Pan, D ^a   Gopalakrishnan, G ^a   Hennessey, J V ^a  

^a BROWN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Autoimmune thyroid disease; Epitopes; Graves' disease; T cells; TSH receptor

Indexed keywords

EPITOPE; RADIOACTIVE IODINE; THYROTROPIN RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EUTHYROIDISM; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION;

EID: 64549147980     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345679     Document Type: Article

References (23)

1. De Groot LJ. Graves' Disease; Chapter 10. Endocrine Education, Inc. www.thyroidmanager.org. Accessed October 10, 2007.
2. Weetman AP. Autoimmune thyroid disease. in: DeGroot LJ, Jameson JL, eds. Endocrinology. 5th Edition. WB Saunders: Philadelphia, 2005, 1979-94.
3. Eisenbarth GS. Update in type 1 diabetes. J Clin Endocrinol Metab 2007, 92: 2403-7.
4. Soliman M, Kaplan E, Yanagawa T, Hidaka Y, Fisfalen ME, DeGroot LJ. T-cells recognize multiple epitopes in the human thyrotropin receptor extra-cellular domain. J Clin Endocrinol Metab 1995, 80: 905-14.
5. Soliman M, Kaplan E, Abdel-Latif A, Scherberg N, DeGroot LJ. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases? J Clin endocrinol Metab 1995, 80: 2312-21.
6. Soliman M, Kaplan E, Guimaraes V, Yanagawa T, DeGroot LJ. T-cell recognition of residue 158-176 in thyrotropin receptor confers risk for development of thyroid autoimmunity in Siblings in a family with Graves' disease. Thyroid 1996, 6: 545-51.
7. Fisfalen ME, Palmer EM, Van Seventer GA, et al. Thyrotropin-receptor and thyroid peroxidase-specific T-cell clones and their cytokine profile in autaimmune thyroid disease. J Clin Endocrinol Metab 1997, 82: 3655-63.
8. Hidaka Y, Guimaraes V, Soliman M, et al. Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor. Endocrinology 1995, 136: 1642-7.
9. Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF. Detection of major T-cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease. J Clin Endocrinol Metab 1997, 82: 3361-6.
10. Tandon N, Freeman MA, Weetman AP. T-cell responses to synthetic TSH receptor peptices in Graves' disease. Clin Exp Immunol 1992, 89: 468-73.
11. Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism. Thyroid 2006, 16: 1221-7.
12. Inaba H, Martin W, De Groot AS, Gin S, De Groot LJ. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. J Clin Endocrinol Metab 2006, 91: 2286-94.
13. Soliman M, Kaplan E, Straus F, et al. Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab 1995, 80: 2848-55.
14. Kamphuis S, Hrafnkelsdottir K, Klein MR, et al. Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. Arthritis Res Ther 2006, 8: R178.
15. You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci U S A 2007, 104: 6335-40.
16. Fenzi G, Hashizume K, Roudebush CP, DeGroot LJ. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab 1979, 48: 572-6.
17. Rubio IG, Silva MN, Knobel M, et al. Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin. J Endocrinol Invest 2007, 30: 535-40.
18. Tan JT, Surh CD. T cell memory. Curr Top Microbiol Immunol 2006, 311: 85-115.
19. DeGroot LJ, Benjasuratwong Y. Evaluation of thyroid ablative therapy for ophthalmopathy of Graves' disease. Orbit 1996, 15: 187-96.
20. Goodell V, dela Rosa C, Slota M, MacLeod B, Disis ML. Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses. BMC Immunol 2007, 8: 21.
21. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006 203: 1693-700.
22. Reijonen H, Novak EJ, Kochik S, et al. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 2002, 51: 1375-82.
23. Guimaraes V, Quintans J, Fisfalen M-E, et al. Suppression of development of experimental autoimmune thyroiditis by oral administration of thyroglobulin. Endocrinology 1995, 136: 3353-9.